标题 |
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
SHR-A1811(一种针对人表皮生长因子受体2的抗体—药物缀合物)在表达或突变的人表皮生长因子受体2的晚期实体瘤中的安全性、有效性和药代动力学:一项全球I期试验
|
网址 | |
DOI | |
求助人 | |
下载 |